Skip to main content

Table 5 Clinical and laboratory markers of infections at the time of receiving the results of PF culture

From: Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation

 

Group 1 (n = 52)

Group 2 (n = 28)

Group 3 (n = 21)

 

Body temperature (°C)

36.2 ± 0.5

36 ± 0.5

36.1 ± 0.5

n.s.

C-reactive protein (mg/mL)

8.3 [1.5–120.8]

12.3 [0.9–43.5]

8.9 [2.5–57.00]

n.s.

Leucocyte count (cells/μL)

7402 ± 2390

6359 ± 2311

7109 ± 1899

n.s.

Time post-transplant of diagnosis of PF contamination (days)

7.1 ± 1.4

6.6 ± 0.8

7.8 ± 1.9

n.s.

Duration of PE-T (days)

11.3 ± 3.9

  1. Continuous variables are presented as mean ± SD or as median [min–max], according to their distribution. The difference between groups was analyzed, respectively, with t-test or Anova and Bonferroni and with Kruskal–Wallis test. Categorical variables are presented as fraction and Pearson’s χ 2 or, for small samples, Fisher’s exact test was employed to compare groups. Significance level for all tests was set at 0.05
  2. Group 1 patients with a pathogen in PF resistant to PAP that underwent PE-T, Group 2 recipients with contaminated PF by an organism sensitive to the PAP and who did not underwent PE-T, Group 3 recipients with a pathogen in PF resistant to PAP who did not underwent PE-T, PF perfusion fluid, PAP perioperative antibiotic prophylaxis, PE-T preemptive antibiotic therapy